nodes	percent_of_prediction	percent_of_DWPC	metapath
Atomoxetine—HTR6—Raloxifene—osteoporosis	0.241	0.422	CbGbCtD
Atomoxetine—CYP2C19—Cholecalciferol—osteoporosis	0.0427	0.0747	CbGbCtD
Atomoxetine—CYP3A4—Estropipate—osteoporosis	0.0401	0.0701	CbGbCtD
Atomoxetine—CYP3A4—Calcitriol—osteoporosis	0.0401	0.0701	CbGbCtD
Atomoxetine—CYP2C19—Estradiol—osteoporosis	0.0345	0.0602	CbGbCtD
Atomoxetine—CYP2D6—Cholecalciferol—osteoporosis	0.0325	0.0568	CbGbCtD
Atomoxetine—CYP3A4—Ergocalciferol—osteoporosis	0.0321	0.056	CbGbCtD
Atomoxetine—CYP3A4—Raloxifene—osteoporosis	0.0268	0.0468	CbGbCtD
Atomoxetine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0258	0.0452	CbGbCtD
Atomoxetine—CYP3A4—Cholecalciferol—osteoporosis	0.0207	0.0361	CbGbCtD
Atomoxetine—CYP3A4—Conjugated Estrogens—osteoporosis	0.019	0.0331	CbGbCtD
Atomoxetine—CYP3A4—Estradiol—osteoporosis	0.0167	0.0291	CbGbCtD
Atomoxetine—Pseudoephedrine—NFATC1—osteoporosis	0.00503	0.842	CrCbGaD
Atomoxetine—Pseudoephedrine—TNF—osteoporosis	0.000591	0.0989	CrCbGaD
Atomoxetine—Methadone—CYP19A1—osteoporosis	0.000352	0.0589	CrCbGaD
Atomoxetine—Nervous system disorder—Pamidronate—osteoporosis	0.000343	0.000976	CcSEcCtD
Atomoxetine—Urinary tract disorder—Estradiol—osteoporosis	0.000342	0.000974	CcSEcCtD
Atomoxetine—Vomiting—Etidronic acid—osteoporosis	0.000342	0.000973	CcSEcCtD
Atomoxetine—Cough—Zoledronate—osteoporosis	0.000341	0.000972	CcSEcCtD
Atomoxetine—Tachycardia—Pamidronate—osteoporosis	0.000341	0.000971	CcSEcCtD
Atomoxetine—Urethral disorder—Estradiol—osteoporosis	0.00034	0.000966	CcSEcCtD
Atomoxetine—Rash—Etidronic acid—osteoporosis	0.000339	0.000965	CcSEcCtD
Atomoxetine—Convulsion—Zoledronate—osteoporosis	0.000339	0.000965	CcSEcCtD
Atomoxetine—Dermatitis—Etidronic acid—osteoporosis	0.000339	0.000964	CcSEcCtD
Atomoxetine—Vertigo—Conjugated Estrogens—osteoporosis	0.000338	0.000963	CcSEcCtD
Atomoxetine—Hyperhidrosis—Pamidronate—osteoporosis	0.000338	0.000962	CcSEcCtD
Atomoxetine—Syncope—Conjugated Estrogens—osteoporosis	0.000338	0.000962	CcSEcCtD
Atomoxetine—Headache—Etidronic acid—osteoporosis	0.000337	0.000959	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000335	0.000954	CcSEcCtD
Atomoxetine—Asthenia—Estropipate—osteoporosis	0.000334	0.00095	CcSEcCtD
Atomoxetine—Anorexia—Pamidronate—osteoporosis	0.000333	0.000948	CcSEcCtD
Atomoxetine—Chest pain—Zoledronate—osteoporosis	0.000333	0.000948	CcSEcCtD
Atomoxetine—Arthralgia—Zoledronate—osteoporosis	0.000333	0.000948	CcSEcCtD
Atomoxetine—Myalgia—Zoledronate—osteoporosis	0.000333	0.000948	CcSEcCtD
Atomoxetine—Palpitations—Conjugated Estrogens—osteoporosis	0.000333	0.000948	CcSEcCtD
Atomoxetine—Insomnia—Risedronate—osteoporosis	0.000333	0.000947	CcSEcCtD
Atomoxetine—Anxiety—Zoledronate—osteoporosis	0.000332	0.000945	CcSEcCtD
Atomoxetine—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000331	0.000942	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000331	0.000942	CcSEcCtD
Atomoxetine—Paraesthesia—Risedronate—osteoporosis	0.00033	0.00094	CcSEcCtD
Atomoxetine—Pruritus—Estropipate—osteoporosis	0.000329	0.000937	CcSEcCtD
Atomoxetine—Asthenia—Alendronate—osteoporosis	0.000329	0.000936	CcSEcCtD
Atomoxetine—Cough—Conjugated Estrogens—osteoporosis	0.000329	0.000936	CcSEcCtD
Atomoxetine—Convulsion—Conjugated Estrogens—osteoporosis	0.000326	0.000929	CcSEcCtD
Atomoxetine—Dry mouth—Zoledronate—osteoporosis	0.000326	0.000927	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000326	0.000927	CcSEcCtD
Atomoxetine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000325	0.000926	CcSEcCtD
Atomoxetine—Pruritus—Alendronate—osteoporosis	0.000324	0.000923	CcSEcCtD
Atomoxetine—Dyspepsia—Risedronate—osteoporosis	0.000324	0.000921	CcSEcCtD
Atomoxetine—Constipation—Ethinyl Estradiol—osteoporosis	0.000323	0.000918	CcSEcCtD
Atomoxetine—Cardiac disorder—Estradiol—osteoporosis	0.000321	0.000915	CcSEcCtD
Atomoxetine—Flushing—Estradiol—osteoporosis	0.000321	0.000915	CcSEcCtD
Atomoxetine—Myalgia—Conjugated Estrogens—osteoporosis	0.000321	0.000913	CcSEcCtD
Atomoxetine—Arthralgia—Conjugated Estrogens—osteoporosis	0.000321	0.000913	CcSEcCtD
Atomoxetine—Chest pain—Conjugated Estrogens—osteoporosis	0.000321	0.000913	CcSEcCtD
Atomoxetine—Asthenia—Ibandronate—osteoporosis	0.00032	0.000911	CcSEcCtD
Atomoxetine—Anxiety—Conjugated Estrogens—osteoporosis	0.00032	0.00091	CcSEcCtD
Atomoxetine—Nausea—Etidronic acid—osteoporosis	0.00032	0.000909	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000319	0.000907	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000319	0.000907	CcSEcCtD
Atomoxetine—Diarrhoea—Estropipate—osteoporosis	0.000318	0.000906	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Risedronate—osteoporosis	0.000317	0.000904	CcSEcCtD
Atomoxetine—Infection—Zoledronate—osteoporosis	0.000317	0.000903	CcSEcCtD
Atomoxetine—Fatigue—Risedronate—osteoporosis	0.000317	0.000902	CcSEcCtD
Atomoxetine—Insomnia—Pamidronate—osteoporosis	0.000316	0.0009	CcSEcCtD
Atomoxetine—Pruritus—Ibandronate—osteoporosis	0.000316	0.000899	CcSEcCtD
Atomoxetine—Constipation—Risedronate—osteoporosis	0.000314	0.000895	CcSEcCtD
Atomoxetine—Pain—Risedronate—osteoporosis	0.000314	0.000895	CcSEcCtD
Atomoxetine—Angiopathy—Estradiol—osteoporosis	0.000314	0.000894	CcSEcCtD
Atomoxetine—Shock—Zoledronate—osteoporosis	0.000314	0.000894	CcSEcCtD
Atomoxetine—Paraesthesia—Pamidronate—osteoporosis	0.000314	0.000893	CcSEcCtD
Atomoxetine—Diarrhoea—Alendronate—osteoporosis	0.000314	0.000893	CcSEcCtD
Atomoxetine—Asthenia—Calcitriol—osteoporosis	0.000313	0.000892	CcSEcCtD
Atomoxetine—Nervous system disorder—Zoledronate—osteoporosis	0.000313	0.000891	CcSEcCtD
Atomoxetine—Mediastinal disorder—Estradiol—osteoporosis	0.000312	0.000888	CcSEcCtD
Atomoxetine—Tachycardia—Zoledronate—osteoporosis	0.000312	0.000887	CcSEcCtD
Atomoxetine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000311	0.000885	CcSEcCtD
Atomoxetine—Chills—Estradiol—osteoporosis	0.000311	0.000885	CcSEcCtD
Atomoxetine—Somnolence—Pamidronate—osteoporosis	0.000311	0.000885	CcSEcCtD
Atomoxetine—Skin disorder—Zoledronate—osteoporosis	0.00031	0.000883	CcSEcCtD
Atomoxetine—Pruritus—Calcitriol—osteoporosis	0.000309	0.00088	CcSEcCtD
Atomoxetine—Hyperhidrosis—Zoledronate—osteoporosis	0.000309	0.000879	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000308	0.000878	CcSEcCtD
Atomoxetine—Diarrhoea—Raloxifene—osteoporosis	0.000308	0.000878	CcSEcCtD
Atomoxetine—Dyspepsia—Pamidronate—osteoporosis	0.000308	0.000876	CcSEcCtD
Atomoxetine—Dizziness—Estropipate—osteoporosis	0.000308	0.000876	CcSEcCtD
Atomoxetine—Infection—Conjugated Estrogens—osteoporosis	0.000305	0.000869	CcSEcCtD
Atomoxetine—Diarrhoea—Ibandronate—osteoporosis	0.000305	0.000869	CcSEcCtD
Atomoxetine—Anorexia—Zoledronate—osteoporosis	0.000304	0.000866	CcSEcCtD
Atomoxetine—Decreased appetite—Pamidronate—osteoporosis	0.000304	0.000865	CcSEcCtD
Atomoxetine—Mental disorder—Estradiol—osteoporosis	0.000303	0.000864	CcSEcCtD
Atomoxetine—Dizziness—Alendronate—osteoporosis	0.000303	0.000863	CcSEcCtD
Atomoxetine—Shock—Conjugated Estrogens—osteoporosis	0.000303	0.000861	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000302	0.000859	CcSEcCtD
Atomoxetine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000302	0.000858	CcSEcCtD
Atomoxetine—Malnutrition—Estradiol—osteoporosis	0.000302	0.000858	CcSEcCtD
Atomoxetine—Fatigue—Pamidronate—osteoporosis	0.000301	0.000858	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Risedronate—osteoporosis	0.000301	0.000856	CcSEcCtD
Atomoxetine—Tachycardia—Conjugated Estrogens—osteoporosis	0.0003	0.000854	CcSEcCtD
Atomoxetine—Urticaria—Ethinyl Estradiol—osteoporosis	0.0003	0.000853	CcSEcCtD
Atomoxetine—Constipation—Pamidronate—osteoporosis	0.000299	0.000851	CcSEcCtD
Atomoxetine—Pain—Pamidronate—osteoporosis	0.000299	0.000851	CcSEcCtD
Atomoxetine—Diarrhoea—Calcitriol—osteoporosis	0.000299	0.000851	CcSEcCtD
Atomoxetine—Skin disorder—Conjugated Estrogens—osteoporosis	0.000299	0.00085	CcSEcCtD
Atomoxetine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000298	0.000849	CcSEcCtD
Atomoxetine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000298	0.000849	CcSEcCtD
Atomoxetine—Dizziness—Raloxifene—osteoporosis	0.000298	0.000848	CcSEcCtD
Atomoxetine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000297	0.000846	CcSEcCtD
Atomoxetine—Flatulence—Estradiol—osteoporosis	0.000297	0.000846	CcSEcCtD
Atomoxetine—Tension—Estradiol—osteoporosis	0.000296	0.000842	CcSEcCtD
Atomoxetine—Vomiting—Estropipate—osteoporosis	0.000296	0.000842	CcSEcCtD
Atomoxetine—Dysgeusia—Estradiol—osteoporosis	0.000295	0.00084	CcSEcCtD
Atomoxetine—Dizziness—Ibandronate—osteoporosis	0.000295	0.00084	CcSEcCtD
Atomoxetine—Rash—Estropipate—osteoporosis	0.000293	0.000835	CcSEcCtD
Atomoxetine—Dermatitis—Estropipate—osteoporosis	0.000293	0.000834	CcSEcCtD
Atomoxetine—Anorexia—Conjugated Estrogens—osteoporosis	0.000293	0.000834	CcSEcCtD
Atomoxetine—Nervousness—Estradiol—osteoporosis	0.000293	0.000834	CcSEcCtD
Atomoxetine—Urticaria—Risedronate—osteoporosis	0.000292	0.000832	CcSEcCtD
Atomoxetine—Back pain—Estradiol—osteoporosis	0.000292	0.00083	CcSEcCtD
Atomoxetine—Headache—Estropipate—osteoporosis	0.000292	0.00083	CcSEcCtD
Atomoxetine—Vomiting—Alendronate—osteoporosis	0.000291	0.000829	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000291	0.000828	CcSEcCtD
Atomoxetine—Body temperature increased—Risedronate—osteoporosis	0.000291	0.000827	CcSEcCtD
Atomoxetine—Abdominal pain—Risedronate—osteoporosis	0.000291	0.000827	CcSEcCtD
Atomoxetine—Muscle spasms—Estradiol—osteoporosis	0.00029	0.000825	CcSEcCtD
Atomoxetine—Rash—Alendronate—osteoporosis	0.000289	0.000823	CcSEcCtD
Atomoxetine—Insomnia—Zoledronate—osteoporosis	0.000289	0.000822	CcSEcCtD
Atomoxetine—Dermatitis—Alendronate—osteoporosis	0.000289	0.000822	CcSEcCtD
Atomoxetine—Feeling abnormal—Pamidronate—osteoporosis	0.000288	0.00082	CcSEcCtD
Atomoxetine—Headache—Alendronate—osteoporosis	0.000287	0.000817	CcSEcCtD
Atomoxetine—Paraesthesia—Zoledronate—osteoporosis	0.000287	0.000816	CcSEcCtD
Atomoxetine—Vomiting—Raloxifene—osteoporosis	0.000287	0.000816	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Pamidronate—osteoporosis	0.000286	0.000814	CcSEcCtD
Atomoxetine—Rash—Raloxifene—osteoporosis	0.000284	0.000809	CcSEcCtD
Atomoxetine—Dermatitis—Raloxifene—osteoporosis	0.000284	0.000808	CcSEcCtD
Atomoxetine—Somnolence—Zoledronate—osteoporosis	0.000284	0.000808	CcSEcCtD
Atomoxetine—Vomiting—Ibandronate—osteoporosis	0.000284	0.000808	CcSEcCtD
Atomoxetine—Tremor—Estradiol—osteoporosis	0.000283	0.000804	CcSEcCtD
Atomoxetine—Headache—Raloxifene—osteoporosis	0.000282	0.000804	CcSEcCtD
Atomoxetine—Rash—Ibandronate—osteoporosis	0.000281	0.000801	CcSEcCtD
Atomoxetine—Dermatitis—Ibandronate—osteoporosis	0.000281	0.0008	CcSEcCtD
Atomoxetine—Dyspepsia—Zoledronate—osteoporosis	0.000281	0.0008	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.00028	0.000797	CcSEcCtD
Atomoxetine—Headache—Ibandronate—osteoporosis	0.00028	0.000796	CcSEcCtD
Atomoxetine—Insomnia—Conjugated Estrogens—osteoporosis	0.000278	0.000792	CcSEcCtD
Atomoxetine—Vomiting—Calcitriol—osteoporosis	0.000278	0.000791	CcSEcCtD
Atomoxetine—Decreased appetite—Zoledronate—osteoporosis	0.000278	0.00079	CcSEcCtD
Atomoxetine—Agitation—Estradiol—osteoporosis	0.000277	0.000789	CcSEcCtD
Atomoxetine—Nausea—Estropipate—osteoporosis	0.000276	0.000787	CcSEcCtD
Atomoxetine—Abdominal pain—Pamidronate—osteoporosis	0.000276	0.000787	CcSEcCtD
Atomoxetine—Body temperature increased—Pamidronate—osteoporosis	0.000276	0.000787	CcSEcCtD
Atomoxetine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000276	0.000786	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000276	0.000785	CcSEcCtD
Atomoxetine—Rash—Calcitriol—osteoporosis	0.000275	0.000784	CcSEcCtD
Atomoxetine—Fatigue—Zoledronate—osteoporosis	0.000275	0.000784	CcSEcCtD
Atomoxetine—Dermatitis—Calcitriol—osteoporosis	0.000275	0.000783	CcSEcCtD
Atomoxetine—Headache—Calcitriol—osteoporosis	0.000274	0.000779	CcSEcCtD
Atomoxetine—Somnolence—Conjugated Estrogens—osteoporosis	0.000273	0.000778	CcSEcCtD
Atomoxetine—Pain—Zoledronate—osteoporosis	0.000273	0.000777	CcSEcCtD
Atomoxetine—Constipation—Zoledronate—osteoporosis	0.000273	0.000777	CcSEcCtD
Atomoxetine—Nausea—Alendronate—osteoporosis	0.000272	0.000775	CcSEcCtD
Atomoxetine—Vertigo—Estradiol—osteoporosis	0.000271	0.000771	CcSEcCtD
Atomoxetine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000271	0.00077	CcSEcCtD
Atomoxetine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000271	0.00077	CcSEcCtD
Atomoxetine—Syncope—Estradiol—osteoporosis	0.00027	0.00077	CcSEcCtD
Atomoxetine—Nausea—Raloxifene—osteoporosis	0.000268	0.000762	CcSEcCtD
Atomoxetine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000267	0.000761	CcSEcCtD
Atomoxetine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000267	0.00076	CcSEcCtD
Atomoxetine—Palpitations—Estradiol—osteoporosis	0.000266	0.000758	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000265	0.000756	CcSEcCtD
Atomoxetine—Fatigue—Conjugated Estrogens—osteoporosis	0.000265	0.000755	CcSEcCtD
Atomoxetine—Nausea—Ibandronate—osteoporosis	0.000265	0.000754	CcSEcCtD
Atomoxetine—Loss of consciousness—Estradiol—osteoporosis	0.000265	0.000754	CcSEcCtD
Atomoxetine—Asthenia—Risedronate—osteoporosis	0.000264	0.000751	CcSEcCtD
Atomoxetine—Feeling abnormal—Zoledronate—osteoporosis	0.000263	0.000749	CcSEcCtD
Atomoxetine—Cough—Estradiol—osteoporosis	0.000263	0.000749	CcSEcCtD
Atomoxetine—Pain—Conjugated Estrogens—osteoporosis	0.000263	0.000748	CcSEcCtD
Atomoxetine—Constipation—Conjugated Estrogens—osteoporosis	0.000263	0.000748	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000261	0.000743	CcSEcCtD
Atomoxetine—Pruritus—Risedronate—osteoporosis	0.00026	0.000741	CcSEcCtD
Atomoxetine—Nausea—Calcitriol—osteoporosis	0.000259	0.000738	CcSEcCtD
Atomoxetine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000258	0.000735	CcSEcCtD
Atomoxetine—Chest pain—Estradiol—osteoporosis	0.000257	0.000731	CcSEcCtD
Atomoxetine—Arthralgia—Estradiol—osteoporosis	0.000257	0.000731	CcSEcCtD
Atomoxetine—Myalgia—Estradiol—osteoporosis	0.000257	0.000731	CcSEcCtD
Atomoxetine—Anxiety—Estradiol—osteoporosis	0.000256	0.000728	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000255	0.000726	CcSEcCtD
Atomoxetine—Urticaria—Zoledronate—osteoporosis	0.000254	0.000722	CcSEcCtD
Atomoxetine—Body temperature increased—Zoledronate—osteoporosis	0.000252	0.000718	CcSEcCtD
Atomoxetine—Abdominal pain—Zoledronate—osteoporosis	0.000252	0.000718	CcSEcCtD
Atomoxetine—Diarrhoea—Risedronate—osteoporosis	0.000252	0.000716	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000251	0.000716	CcSEcCtD
Atomoxetine—Dry mouth—Estradiol—osteoporosis	0.000251	0.000715	CcSEcCtD
Atomoxetine—Asthenia—Pamidronate—osteoporosis	0.000251	0.000714	CcSEcCtD
Atomoxetine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000249	0.00071	CcSEcCtD
Atomoxetine—Pruritus—Pamidronate—osteoporosis	0.000247	0.000704	CcSEcCtD
Atomoxetine—Infection—Estradiol—osteoporosis	0.000244	0.000696	CcSEcCtD
Atomoxetine—Urticaria—Conjugated Estrogens—osteoporosis	0.000244	0.000695	CcSEcCtD
Atomoxetine—Dizziness—Risedronate—osteoporosis	0.000243	0.000692	CcSEcCtD
Atomoxetine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000243	0.000692	CcSEcCtD
Atomoxetine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000243	0.000692	CcSEcCtD
Atomoxetine—Shock—Estradiol—osteoporosis	0.000242	0.000689	CcSEcCtD
Atomoxetine—Nervous system disorder—Estradiol—osteoporosis	0.000241	0.000687	CcSEcCtD
Atomoxetine—Tachycardia—Estradiol—osteoporosis	0.00024	0.000684	CcSEcCtD
Atomoxetine—Vomiting—Ethinyl Estradiol—osteoporosis	0.00024	0.000683	CcSEcCtD
Atomoxetine—Diarrhoea—Pamidronate—osteoporosis	0.000239	0.000681	CcSEcCtD
Atomoxetine—Skin disorder—Estradiol—osteoporosis	0.000239	0.00068	CcSEcCtD
Atomoxetine—Hyperhidrosis—Estradiol—osteoporosis	0.000238	0.000677	CcSEcCtD
Atomoxetine—Rash—Ethinyl Estradiol—osteoporosis	0.000238	0.000677	CcSEcCtD
Atomoxetine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000238	0.000676	CcSEcCtD
Atomoxetine—Headache—Ethinyl Estradiol—osteoporosis	0.000236	0.000673	CcSEcCtD
Atomoxetine—Vomiting—Risedronate—osteoporosis	0.000234	0.000666	CcSEcCtD
Atomoxetine—Rash—Risedronate—osteoporosis	0.000232	0.00066	CcSEcCtD
Atomoxetine—Dermatitis—Risedronate—osteoporosis	0.000232	0.000659	CcSEcCtD
Atomoxetine—Dizziness—Pamidronate—osteoporosis	0.000231	0.000658	CcSEcCtD
Atomoxetine—Headache—Risedronate—osteoporosis	0.00023	0.000656	CcSEcCtD
Atomoxetine—Asthenia—Zoledronate—osteoporosis	0.000229	0.000652	CcSEcCtD
Atomoxetine—Pruritus—Zoledronate—osteoporosis	0.000226	0.000643	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000224	0.000638	CcSEcCtD
Atomoxetine—Nausea—Ethinyl Estradiol—osteoporosis	0.000224	0.000638	CcSEcCtD
Atomoxetine—Insomnia—Estradiol—osteoporosis	0.000223	0.000633	CcSEcCtD
Atomoxetine—Vomiting—Pamidronate—osteoporosis	0.000222	0.000633	CcSEcCtD
Atomoxetine—Paraesthesia—Estradiol—osteoporosis	0.000221	0.000629	CcSEcCtD
Atomoxetine—Asthenia—Conjugated Estrogens—osteoporosis	0.000221	0.000628	CcSEcCtD
Atomoxetine—Rash—Pamidronate—osteoporosis	0.00022	0.000627	CcSEcCtD
Atomoxetine—Dermatitis—Pamidronate—osteoporosis	0.00022	0.000627	CcSEcCtD
Atomoxetine—Headache—Pamidronate—osteoporosis	0.000219	0.000623	CcSEcCtD
Atomoxetine—Somnolence—Estradiol—osteoporosis	0.000219	0.000623	CcSEcCtD
Atomoxetine—Diarrhoea—Zoledronate—osteoporosis	0.000218	0.000622	CcSEcCtD
Atomoxetine—Nausea—Risedronate—osteoporosis	0.000218	0.000622	CcSEcCtD
Atomoxetine—Pruritus—Conjugated Estrogens—osteoporosis	0.000218	0.000619	CcSEcCtD
Atomoxetine—Dyspepsia—Estradiol—osteoporosis	0.000217	0.000617	CcSEcCtD
Atomoxetine—Decreased appetite—Estradiol—osteoporosis	0.000214	0.000609	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Estradiol—osteoporosis	0.000212	0.000605	CcSEcCtD
Atomoxetine—Fatigue—Estradiol—osteoporosis	0.000212	0.000604	CcSEcCtD
Atomoxetine—Dizziness—Zoledronate—osteoporosis	0.000211	0.000601	CcSEcCtD
Atomoxetine—Pain—Estradiol—osteoporosis	0.00021	0.000599	CcSEcCtD
Atomoxetine—Constipation—Estradiol—osteoporosis	0.00021	0.000599	CcSEcCtD
Atomoxetine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00021	0.000599	CcSEcCtD
Atomoxetine—Nausea—Pamidronate—osteoporosis	0.000208	0.000591	CcSEcCtD
Atomoxetine—Dizziness—Conjugated Estrogens—osteoporosis	0.000203	0.000579	CcSEcCtD
Atomoxetine—Vomiting—Zoledronate—osteoporosis	0.000203	0.000578	CcSEcCtD
Atomoxetine—Feeling abnormal—Estradiol—osteoporosis	0.000203	0.000577	CcSEcCtD
Atomoxetine—Rash—Zoledronate—osteoporosis	0.000201	0.000573	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Estradiol—osteoporosis	0.000201	0.000573	CcSEcCtD
Atomoxetine—Dermatitis—Zoledronate—osteoporosis	0.000201	0.000573	CcSEcCtD
Atomoxetine—Headache—Zoledronate—osteoporosis	0.0002	0.000569	CcSEcCtD
Atomoxetine—Vomiting—Conjugated Estrogens—osteoporosis	0.000196	0.000556	CcSEcCtD
Atomoxetine—Urticaria—Estradiol—osteoporosis	0.000195	0.000556	CcSEcCtD
Atomoxetine—Body temperature increased—Estradiol—osteoporosis	0.000195	0.000554	CcSEcCtD
Atomoxetine—Abdominal pain—Estradiol—osteoporosis	0.000195	0.000554	CcSEcCtD
Atomoxetine—Rash—Conjugated Estrogens—osteoporosis	0.000194	0.000552	CcSEcCtD
Atomoxetine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000194	0.000551	CcSEcCtD
Atomoxetine—Headache—Conjugated Estrogens—osteoporosis	0.000193	0.000548	CcSEcCtD
Atomoxetine—Nausea—Zoledronate—osteoporosis	0.00019	0.00054	CcSEcCtD
Atomoxetine—Nausea—Conjugated Estrogens—osteoporosis	0.000183	0.00052	CcSEcCtD
Atomoxetine—Asthenia—Estradiol—osteoporosis	0.000177	0.000503	CcSEcCtD
Atomoxetine—Pruritus—Estradiol—osteoporosis	0.000174	0.000496	CcSEcCtD
Atomoxetine—Diarrhoea—Estradiol—osteoporosis	0.000168	0.000479	CcSEcCtD
Atomoxetine—Dizziness—Estradiol—osteoporosis	0.000163	0.000463	CcSEcCtD
Atomoxetine—Vomiting—Estradiol—osteoporosis	0.000156	0.000445	CcSEcCtD
Atomoxetine—Rash—Estradiol—osteoporosis	0.000155	0.000442	CcSEcCtD
Atomoxetine—Dermatitis—Estradiol—osteoporosis	0.000155	0.000441	CcSEcCtD
Atomoxetine—Headache—Estradiol—osteoporosis	0.000154	0.000439	CcSEcCtD
Atomoxetine—Nausea—Estradiol—osteoporosis	0.000146	0.000416	CcSEcCtD
Atomoxetine—HTR6—Signaling Pathways—RAP1A—osteoporosis	4.4e-05	0.000625	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—RAP1A—osteoporosis	4.37e-05	0.00062	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CNR2—osteoporosis	4.37e-05	0.00062	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—PTH—osteoporosis	4.35e-05	0.000618	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—ADCY5—osteoporosis	4.33e-05	0.000615	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—MGLL—osteoporosis	4.33e-05	0.000615	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CNR2—osteoporosis	4.33e-05	0.000615	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—ADCY5—osteoporosis	4.3e-05	0.000611	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—NFATC1—osteoporosis	4.29e-05	0.00061	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—RAP1A—osteoporosis	4.28e-05	0.000608	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—FDPS—osteoporosis	4.28e-05	0.000607	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PKM—osteoporosis	4.28e-05	0.000607	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—NFATC1—osteoporosis	4.26e-05	0.000605	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—DKK1—osteoporosis	4.26e-05	0.000605	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CNR2—osteoporosis	4.24e-05	0.000602	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—LRP5—osteoporosis	4.23e-05	0.000601	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—DKK1—osteoporosis	4.23e-05	0.000601	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—ADCY5—osteoporosis	4.21e-05	0.000598	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—NFATC1—osteoporosis	4.17e-05	0.000593	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—POMC—osteoporosis	4.15e-05	0.00059	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—DKK1—osteoporosis	4.14e-05	0.000588	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—WNT1—osteoporosis	4.1e-05	0.000583	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—CALCA—osteoporosis	4.07e-05	0.000579	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—WNT1—osteoporosis	4.07e-05	0.000578	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—GPD2—osteoporosis	4.05e-05	0.000576	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PGLS—osteoporosis	4.05e-05	0.000576	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—LRP6—osteoporosis	4.04e-05	0.000574	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—ATIC—osteoporosis	4.03e-05	0.000572	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—PNP—osteoporosis	4.03e-05	0.000572	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—PTHLH—osteoporosis	4.02e-05	0.000571	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—FGA—osteoporosis	3.99e-05	0.000567	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—WNT1—osteoporosis	3.99e-05	0.000566	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—FGA—osteoporosis	3.96e-05	0.000563	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—ADCY5—osteoporosis	3.93e-05	0.000559	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—TLN1—osteoporosis	3.93e-05	0.000559	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—ADCY5—osteoporosis	3.9e-05	0.000555	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—CALCA—osteoporosis	3.9e-05	0.000553	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—FGA—osteoporosis	3.88e-05	0.000551	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—ADCY5—osteoporosis	3.82e-05	0.000543	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—PTHLH—osteoporosis	3.71e-05	0.000527	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—BMP2—osteoporosis	3.71e-05	0.000527	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—ATIC—osteoporosis	3.71e-05	0.000526	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PNP—osteoporosis	3.71e-05	0.000526	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—PTHLH—osteoporosis	3.68e-05	0.000523	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—BMP2—osteoporosis	3.68e-05	0.000523	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—FGB—osteoporosis	3.63e-05	0.000516	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—PTHLH—osteoporosis	3.61e-05	0.000512	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—BMP2—osteoporosis	3.61e-05	0.000512	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—POMC—osteoporosis	3.61e-05	0.000512	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—FGB—osteoporosis	3.6e-05	0.000512	CbGpPWpGaD
Atomoxetine—HTR2A—SIDS Susceptibility Pathways—IL6—osteoporosis	3.59e-05	0.00051	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CALCA—osteoporosis	3.54e-05	0.000502	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—FGB—osteoporosis	3.53e-05	0.000501	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—PSMA2—osteoporosis	3.51e-05	0.000498	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—PSMA5—osteoporosis	3.51e-05	0.000498	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—PSMA2—osteoporosis	3.48e-05	0.000494	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—PSMA5—osteoporosis	3.48e-05	0.000494	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—OXCT1—osteoporosis	3.43e-05	0.000487	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—CA2—osteoporosis	3.43e-05	0.000487	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—TLN1—osteoporosis	3.41e-05	0.000485	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling by GPCR—IL6—osteoporosis	3.41e-05	0.000484	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—PSMA2—osteoporosis	3.41e-05	0.000484	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—PSMA5—osteoporosis	3.41e-05	0.000484	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—P4HB—osteoporosis	3.39e-05	0.000482	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—MGLL—osteoporosis	3.34e-05	0.000474	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—PTH—osteoporosis	3.3e-05	0.000468	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CALCA—osteoporosis	3.27e-05	0.000464	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CALCA—osteoporosis	3.24e-05	0.000461	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—RAP1A—osteoporosis	3.24e-05	0.00046	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CNR2—osteoporosis	3.21e-05	0.000457	CbGpPWpGaD
Atomoxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	3.2e-05	0.000455	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—ADCY5—osteoporosis	3.19e-05	0.000453	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—POMC—osteoporosis	3.19e-05	0.000453	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CALCA—osteoporosis	3.18e-05	0.000451	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—POMC—osteoporosis	3.16e-05	0.000449	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—NFATC1—osteoporosis	3.16e-05	0.000449	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—OXCT1—osteoporosis	3.15e-05	0.000448	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—CA2—osteoporosis	3.15e-05	0.000448	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.15e-05	0.000447	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—DKK1—osteoporosis	3.14e-05	0.000446	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—POMC—osteoporosis	3.1e-05	0.00044	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—MGLL—osteoporosis	3.07e-05	0.000436	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—WNT1—osteoporosis	3.02e-05	0.000429	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—KL—osteoporosis	2.97e-05	0.000421	CbGpPWpGaD
Atomoxetine—CYP3A4—Biological oxidations—POMC—osteoporosis	2.96e-05	0.000421	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—P4HB—osteoporosis	2.94e-05	0.000418	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—KL—osteoporosis	2.94e-05	0.000418	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—FGA—osteoporosis	2.94e-05	0.000418	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—ADCY5—osteoporosis	2.9e-05	0.000412	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—POMC—osteoporosis	2.89e-05	0.000411	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—KL—osteoporosis	2.88e-05	0.000409	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—POMC—osteoporosis	2.87e-05	0.000408	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—PTH—osteoporosis	2.86e-05	0.000407	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—IDH2—osteoporosis	2.84e-05	0.000403	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—IL6R—osteoporosis	2.82e-05	0.000401	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—RAP1A—osteoporosis	2.82e-05	0.0004	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—POMC—osteoporosis	2.81e-05	0.000399	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—IL6R—osteoporosis	2.8e-05	0.000398	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—FDPS—osteoporosis	2.8e-05	0.000397	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PKM—osteoporosis	2.8e-05	0.000397	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CNR2—osteoporosis	2.79e-05	0.000396	CbGpPWpGaD
Atomoxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	2.78e-05	0.000395	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—ADCY5—osteoporosis	2.77e-05	0.000394	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—NFATC1—osteoporosis	2.75e-05	0.00039	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—IL6R—osteoporosis	2.74e-05	0.00039	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—PTHLH—osteoporosis	2.73e-05	0.000388	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—BMP2—osteoporosis	2.73e-05	0.000388	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—DKK1—osteoporosis	2.72e-05	0.000387	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—MYC—osteoporosis	2.68e-05	0.000381	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—FGB—osteoporosis	2.67e-05	0.00038	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—TGFB1—osteoporosis	2.67e-05	0.00038	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—CYP27A1—osteoporosis	2.67e-05	0.000379	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—GPD2—osteoporosis	2.65e-05	0.000376	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PGLS—osteoporosis	2.65e-05	0.000376	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—WNT1—osteoporosis	2.62e-05	0.000373	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—IDH2—osteoporosis	2.61e-05	0.000371	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—ACP5—osteoporosis	2.6e-05	0.000369	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—PSMA2—osteoporosis	2.58e-05	0.000367	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—PSMA5—osteoporosis	2.58e-05	0.000367	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.56e-05	0.000364	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—FGA—osteoporosis	2.55e-05	0.000363	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—ADCY5—osteoporosis	2.52e-05	0.000357	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—CYP27A1—osteoporosis	2.46e-05	0.000349	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PNP—osteoporosis	2.42e-05	0.000344	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ATIC—osteoporosis	2.42e-05	0.000344	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—TPI1—osteoporosis	2.41e-05	0.000343	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CALCA—osteoporosis	2.41e-05	0.000342	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—ACP5—osteoporosis	2.39e-05	0.000339	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—PTHLH—osteoporosis	2.37e-05	0.000337	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—BMP2—osteoporosis	2.37e-05	0.000337	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—POMC—osteoporosis	2.35e-05	0.000333	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—ADCY5—osteoporosis	2.32e-05	0.00033	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—FGB—osteoporosis	2.32e-05	0.00033	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—ADCY5—osteoporosis	2.31e-05	0.000328	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—P4HB—osteoporosis	2.27e-05	0.000322	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—ADCY5—osteoporosis	2.26e-05	0.000321	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—SPP1—osteoporosis	2.25e-05	0.000319	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—PSMA2—osteoporosis	2.24e-05	0.000318	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—PSMA5—osteoporosis	2.24e-05	0.000318	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—SPP1—osteoporosis	2.23e-05	0.000317	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—GAPDH—osteoporosis	2.23e-05	0.000316	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—TPI1—osteoporosis	2.22e-05	0.000315	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—SPP1—osteoporosis	2.19e-05	0.00031	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—KL—osteoporosis	2.19e-05	0.00031	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—RAP1A—osteoporosis	2.17e-05	0.000308	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—POMC—osteoporosis	2.13e-05	0.000303	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CALCA—osteoporosis	2.09e-05	0.000297	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—P4HB—osteoporosis	2.09e-05	0.000297	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—IL6R—osteoporosis	2.08e-05	0.000295	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—CA2—osteoporosis	2.06e-05	0.000293	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—OXCT1—osteoporosis	2.06e-05	0.000293	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—GAPDH—osteoporosis	2.05e-05	0.000291	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—POMC—osteoporosis	2.04e-05	0.000289	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—IRS2—osteoporosis	2.03e-05	0.000289	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—IRS2—osteoporosis	2.02e-05	0.000287	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—IL6—osteoporosis	2.01e-05	0.000286	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—MGLL—osteoporosis	2.01e-05	0.000285	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—RAP1A—osteoporosis	2e-05	0.000283	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—LEP—osteoporosis	1.99e-05	0.000283	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—IRS2—osteoporosis	1.98e-05	0.000281	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—LEP—osteoporosis	1.98e-05	0.00028	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—LEP—osteoporosis	1.93e-05	0.000275	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—ESR1—osteoporosis	1.9e-05	0.00027	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—KL—osteoporosis	1.9e-05	0.000269	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.89e-05	0.000269	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—ESR1—osteoporosis	1.89e-05	0.000268	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—POMC—osteoporosis	1.85e-05	0.000263	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—ESR1—osteoporosis	1.85e-05	0.000262	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—IL6R—osteoporosis	1.81e-05	0.000256	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—IRS1—osteoporosis	1.78e-05	0.000252	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—IRS1—osteoporosis	1.76e-05	0.00025	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—ENO1—osteoporosis	1.75e-05	0.000249	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—PSMA5—osteoporosis	1.73e-05	0.000245	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—PSMA2—osteoporosis	1.73e-05	0.000245	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—IRS1—osteoporosis	1.73e-05	0.000245	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—ADCY5—osteoporosis	1.71e-05	0.000243	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—POMC—osteoporosis	1.71e-05	0.000243	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—IDH2—osteoporosis	1.71e-05	0.000242	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—POMC—osteoporosis	1.7e-05	0.000241	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—IL6R—osteoporosis	1.67e-05	0.000237	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—POMC—osteoporosis	1.66e-05	0.000236	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—SPP1—osteoporosis	1.66e-05	0.000235	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—IL6R—osteoporosis	1.66e-05	0.000235	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—IGF1—osteoporosis	1.64e-05	0.000234	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—IGF1—osteoporosis	1.63e-05	0.000232	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—IL6R—osteoporosis	1.62e-05	0.00023	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—ENO1—osteoporosis	1.61e-05	0.000229	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.61e-05	0.000228	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—IGF1—osteoporosis	1.6e-05	0.000227	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PSMA5—osteoporosis	1.59e-05	0.000226	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PSMA2—osteoporosis	1.59e-05	0.000226	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ACP5—osteoporosis	1.56e-05	0.000222	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—IRS2—osteoporosis	1.5e-05	0.000213	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—ADCY5—osteoporosis	1.49e-05	0.000211	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—LEP—osteoporosis	1.47e-05	0.000208	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—TPI1—osteoporosis	1.45e-05	0.000206	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—SPP1—osteoporosis	1.44e-05	0.000204	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—CYP19A1—osteoporosis	1.4e-05	0.000199	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—ESR1—osteoporosis	1.4e-05	0.000199	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—P4HB—osteoporosis	1.36e-05	0.000194	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—GAPDH—osteoporosis	1.34e-05	0.00019	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—IRS1—osteoporosis	1.31e-05	0.000186	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—RAP1A—osteoporosis	1.3e-05	0.000185	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—IRS2—osteoporosis	1.3e-05	0.000185	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—CYP19A1—osteoporosis	1.29e-05	0.000183	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—LEP—osteoporosis	1.27e-05	0.000181	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—POMC—osteoporosis	1.26e-05	0.000179	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—IL6—osteoporosis	1.26e-05	0.000179	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—IL6—osteoporosis	1.25e-05	0.000177	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—IL6R—osteoporosis	1.23e-05	0.000174	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—IL6—osteoporosis	1.22e-05	0.000174	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—ESR1—osteoporosis	1.22e-05	0.000173	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—IGF1—osteoporosis	1.21e-05	0.000172	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—ADCY5—osteoporosis	1.15e-05	0.000163	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—GPX1—osteoporosis	1.14e-05	0.000162	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—IRS1—osteoporosis	1.14e-05	0.000161	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—POMC—osteoporosis	1.09e-05	0.000155	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—IL6R—osteoporosis	1.07e-05	0.000151	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ENO1—osteoporosis	1.05e-05	0.00015	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—ADCY5—osteoporosis	1.05e-05	0.00015	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—MTHFR—osteoporosis	1.05e-05	0.00015	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—IGF1—osteoporosis	1.05e-05	0.000149	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—GPX1—osteoporosis	1.05e-05	0.000149	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PSMA2—osteoporosis	1.04e-05	0.000148	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PSMA5—osteoporosis	1.04e-05	0.000148	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—MYC—osteoporosis	9.88e-06	0.00014	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—TGFB1—osteoporosis	9.86e-06	0.00014	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—MYC—osteoporosis	9.81e-06	0.000139	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—TGFB1—osteoporosis	9.78e-06	0.000139	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—MTHFR—osteoporosis	9.69e-06	0.000138	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—MYC—osteoporosis	9.6e-06	0.000136	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—TGFB1—osteoporosis	9.58e-06	0.000136	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—IL6—osteoporosis	9.26e-06	0.000132	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—CYP19A1—osteoporosis	8.43e-06	0.00012	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—POMC—osteoporosis	8.43e-06	0.00012	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—IL6—osteoporosis	8.04e-06	0.000114	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—POMC—osteoporosis	7.75e-06	0.00011	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—IL6—osteoporosis	7.43e-06	0.000106	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—IL6—osteoporosis	7.37e-06	0.000105	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—MYC—osteoporosis	7.28e-06	0.000103	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—TGFB1—osteoporosis	7.26e-06	0.000103	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—IL6—osteoporosis	7.22e-06	0.000103	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ADCY5—osteoporosis	6.89e-06	9.79e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—GPX1—osteoporosis	6.87e-06	9.75e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—MTHFR—osteoporosis	6.34e-06	9e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—MYC—osteoporosis	6.32e-06	8.98e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—TGFB1—osteoporosis	6.3e-06	8.95e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—IL6—osteoporosis	5.47e-06	7.77e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—POMC—osteoporosis	5.07e-06	7.2e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—IL6—osteoporosis	4.75e-06	6.75e-05	CbGpPWpGaD
